UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:
www.oncology-forum.co.uk/register

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By BOPA on 22nd January 2026

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students   Through an open letter published on its website, the UK Pharmacy Professional Leadership Advisory Board is inviting…

Read article
By BOPA Executive Committee on 20th January 2026

Join NCODA in Dublin, Ireland from 11-12 March for the 2026 NCODA Global Oncology & Haematology Congress 

Join NCODA in Dublin, Ireland from 11-12 March for the 2026 NCODA Global Oncology & Haematology Congress — a new international meeting designed to unite leaders in oncology, hematology, diagnostics, and technology for two days of…

Read article
By BOPA Executive Committee on 20th January 2026

The HMP Safety Campaign page is now live!

The HMP Safety Campaign page is now live on the SHBN website: https://shbn.org.uk/hmp-safety/ The campaign has been established to address the ongoing risks faced by healthcare professionals who prepare, administer,…

Read article
By BOPA Research committee on 15th January 2026

Allied health and lifestyle support provision research survey

Dear members, Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) are working on behalf of Pfizer to identify the type of information, support and services offered to people living with metastatic…

Read article